Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>IMS</strong> COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING<br />
Tel: +31 26 378 21 00<br />
Fax: +31 26 364 05 67<br />
Home Page: www.novartis.nl<br />
De scrip tion: De vel oper, im porter, pro moter,<br />
sales/detailer. Sells/de tails for other com pa nies.<br />
Prod uct ranges in clude: phar ma ceu ti cal prod ucts<br />
(branded, pre scrip tion, non-pre scrip tion), hos pi -<br />
tal pharmaceuticals. Es tab lished 1997. 25 phar -<br />
ma ceu ti cal em ploy ees in 2005. Di vi sions include:<br />
Pharmaceutical; OTC.<br />
Rep re sen ta tives/De tail ers (Pharm, Num -<br />
ber): 11-20 (2005)<br />
Sub sid iary of: Novartis, Swit zer land (100%)<br />
Phar ma ceu ti cal Sales: US$ 190-200 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 65-70%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 70-75%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
90-95%<br />
Prin ci pal Prod ucts:<br />
GLIVEC (antineoplastic other)<br />
DIOVAN (an gio ten sin-II an tag o nist plain)<br />
SANDOSTATINE (hor mone hy po tha lamic)<br />
CODIOVAN (an gio ten sin-II an tag o nist com bi na -<br />
tion)<br />
FORADIL (B2-stim u lant)<br />
Ther a peu tic Range:<br />
renin-an gio ten sin sys tem agents 29%<br />
antineoplastics 23%<br />
hor mones pi tu itary and hy po tha lamic 11%<br />
antiasthma and COPD prod ucts 7%<br />
CNS drugs other 5%<br />
Lead ing Dose Forms:<br />
coated tab lets 62%<br />
vi als 10%<br />
cap sules 7%<br />
pres sur ised aero sols 6%<br />
tab lets 6%<br />
NOVARTIS CON SUMER HEALTH<br />
Full Name: Novartis Con sumer Health B.V.<br />
Postal Ad dress: Postbus 2014, 4800 CA Breda<br />
Street Ad dress: Clau dius Prinsenlaan 142, 4818<br />
CP Breda<br />
Tel: +31 76 533 00 00<br />
Fax: +31 76 533 00 44<br />
Home Page: www.novartisconsumerhealth.nl<br />
De scrip tion: Dis trib u tor, sales/detailer. Prod uct<br />
ranges in clude: phar ma ceu ti cal prod ucts<br />
(branded, pre scrip tion, non-pre scrip tion). 13<br />
phar ma ceu ti cal employees in 2007.<br />
Rep re sen ta tives/De tail ers (Pharm, Num -<br />
ber): 3 (2007)<br />
Con tacts (Pharm): Chair man: Jalmar Wesslink;<br />
Com mer cial Op er a tions: Bas Vorste Veld; Mar ket<br />
Re search: Rieny Fokker; Gen eral Con tact: Rieny<br />
Fokker<br />
Sub sid iary of: Novartis, Swit zer land (100%)<br />
SANDOZ<br />
Postal Ad dress: Postbus 10332, 1301 AH<br />
Almere<br />
Street Ad dress: Veluwezoom 22, 1327 AH<br />
Almere<br />
Tel: +31 36 524 16 00<br />
Fax: +31 36 537 33 22<br />
Home Page: www.sandoz.nl<br />
De scrip tion: Dis trib u tor, pro moter,<br />
sales/detailer. Im ports, dis trib utes, pro motes,<br />
sells/de tails for other com pa nies. Prod uct ranges<br />
in clude: phar ma ceu ti cal prod ucts (branded,<br />
unbranded, pre scrip tion, non-pre scrip tion), hos -<br />
pi tal pharmaceuticals. Es tab lished 1963. 57 phar -<br />
ma ceu ti cal employees in 2005.<br />
Rep re sen ta tives/De tail ers (Pharm, Num -<br />
ber): 7 (2005)<br />
Con tacts (Pharm): Chair man: E. Gorka; Com -<br />
mer cial Op er a tions: H. Mol; Gen eral Con tact:<br />
Denise Heuberger<br />
Sub sid iary of: Novartis, Swit zer land (100%)<br />
Phar ma ceu ti cal Sales: US$ 230-240 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 30-35%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 45-50%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
95-100%<br />
Prin ci pal Prod ucts:<br />
METOPROLOL-SDZ (beta-blocker agent plain)<br />
OMEPRAZOL-SDZ (antiulcerant)<br />
NIFEDIPINE-SDZ (cal cium an tag o nist plain)<br />
SIMVASTATINE-SDZ (cho les terol/triglyceride<br />
reg u lat ing prep a ra tion)<br />
PRAVASTATIN.NA-SDZ (cho les terol/triglyceride<br />
reg u lat ing prep a ra tion)<br />
Ther a peu tic Range:<br />
beta-block ing agents 24%<br />
ant ac ids/antiflatulents/antiulcerants 7%<br />
renin-an gio ten sin sys tem agents 7%<br />
psychoanaleptics 6%<br />
antibacterials sys temic 6%<br />
Lead ing Dose Forms:<br />
tab lets 61%<br />
coated tab lets 20%<br />
© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 190